Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Psychoactive Drugs is Scopus-indexed (Q2, CiteScore 4.9), WoS SSCI. It is covered by India's One Nation One Subscription scheme for reading access. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 0279-1072Verify ISSN ↗2159-9777Verify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (miscellaneous) | 122 / 466 | 73rd | Q2 |
| Psychology (all) | 62 / 220 | 72nd | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1974–present (also 1967–1972), best quartile Q2, CiteScore 4.9.
Journal of Psychoactive Drugs is Q2 in Medicine (miscellaneous) (rank 122 of 466) and Q2 in Psychology (all) (rank 62 of 220), by CiteScore 2025.
Journal of Psychoactive Drugs is indexed in the Social Sciences Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.9, which places it in quartile Q2 at the 73rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.700, quartile Q2, with an H-index of 80.
Journal of Psychoactive Drugs is published by Taylor and Francis Ltd. Its print ISSN is 0279-1072 and its online ISSN is 2159-9777.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Social Sciences Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Journal of Psychoactive Drugs has an h-index of 106 and a 2-year mean of 2.38 citations per paper (OpenAlex). Its Scopus CiteScore is 4.9, quartile Q2. On 2-year citations it ranks #138 of 451 Scopus journals in Medicine (miscellaneous).
Journal of Psychoactive Drugs published 87 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2025–2026), authors are most often from United States (59.4%), United Kingdom (4.2%) and Brazil (3.9%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.